Principal Financial Group’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Principal Financial Group’s Portfolio OCDX Stock Details OCDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-21,871	Closed	-$408K	–	2716
2022 Q1	$408K	Buy	21,871 +1,390	+7%	+$25K	﹤0.01%	2167
2021 Q4	$438K	Sell	20,481 -2,734	-12%	-$53.9K	﹤0.01%	2154
2021 Q3	$429K	Buy	23,215 +9,067	+64%	+$183K	﹤0.01%	2213
2021 Q2	$303K	Sell	14,148 -2,657	-16%	-$54K	﹤0.01%	2353
2021 Q1	$324K	Buy	+16,805	New	+$296K	﹤0.01%	2256

Other funds holding OCDX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Principal Financial Group's OCDX Position: Q2 2022 in Review

Principal Financial Group sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 21,871 shares — an estimated $408K sold.

Principal Financial Group first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $438K in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

Principal Financial Group reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
Principal Financial Group sold 21,871 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $408K.
Principal Financial Group first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 5 quarters.
Principal Financial Group's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $438K in Q4 2021.
1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Principal Financial Group's 13F filing for Q2 2022, filed 10 Aug 2022.